Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Shared COVID- and chemo-fog

Cell (2022)

Even after seemingly mild infection with SARS-CoV-2, many suffer from persistent cognitive impairment, or ‘COVID brain fog’, that resembles the ‘chemo-fog’ associated with cancer therapy. Chemo-fog is known to be mediated by microglial reactivity and subsequent neural dysregulation, and a study published in Cell investigated whether COVID recruits similar pathophysiological processes. In a mouse model of mild respiratory SARS-CoV-2 infection, the authors observed elevated cytokines and chemokines in serum and cerebrospinal fluid, increased microglial reactivity specifically in white matter, a loss of oligodendrocytes and myelin, and decreased hippocampal neurogenesis. These changes persisted for many weeks after the respiratory infection had cleared, and had human counterparts: brain tissue from patients with COVID-19 also showed white-matter-specific microglial reactivity and, intriguingly, cytokine CCL11 levels were higher in the plasma of patients with long-COVID who had ‘brain-fog’ than in plasma from patients without cognitive symptoms. Systemic CCL11 injection in mice induced white-matter microglial reactivity in hippocampus, along with impaired neurogenesis. Mild respiratory influenza in mice caused similar neuroinflammation and hippocampal pathology, but only transient subcortical white-matter changes. This work starts to unravel the mechanisms that underlie persistent COVID-related cognitive impairments, opening the door for future studies on how these mechanisms may depend on COVID-19 variant, vaccination status and age.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Charlotte Arlt.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Arlt, C. Shared COVID- and chemo-fog. Nat Neurosci 25, 838 (2022).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing